The Mexico Tourism Board (MTB) reported that its 2017 Meetings and Events program has led to significant growth in the industry sector, showing a 6.7% increase from January to October, when compared to the same period in 2016. Mexico has taken a leadership position as a destination for meetings and events with the relaunch of its strategic partnership program with meetings industry organizations and initiatives that aim to elevate its ICCA ranking, as well as to increase the economic impact of the meetings and conventions industry in the Mexican economy, which currently accounts for US$25 billion. The International Congress and Convention Association (ICCA) ranks Mexico as 3rd in Latin America, 5th in the Americas, and 21st globally for meeting and incentive travel.
“The meetings and convention industry is a crucial part of our growth plan focused on elevating the average expenditure of travelers,” said Hector Flores, CEO of the Mexico Tourism Board. “We are continuing to invest in building Mexico’s profile for business events and are working closely with industry leaders around the world to bring more corporate and association events to Mexico while introducing them to destinations beyond our traditional sun and beach offerings.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8242051-mexico-tourism-meetings-events/
The disaster at Japan’s Fukushima nuclear power station has made eminently clear that mankind has to look for alternative ways of meeting its energy needs – and quickly. Because demand for energy continues to rise. Today, every second person on the planet lives in a city. In Europe, this figure has passed the 70 percent mark. Urban centers around the globe account for over three quarters of worldwide energy consumption. That’s why the experts are working all-out on developing so-called “Metropolitan Solutions” – environmentally friendly energy supply and utility services concepts for today’s large urban centers.
Planning a well-crafted, creative and inspiring meeting has become an art form with limitless possibilities. Marriott International hosts thousands of meetings every year and has drawn on the company’s brand differentiation, expertise and talent to launch an industry first, Meetings Imagined, a new set of tools to help any planner design and manage the perfect meeting experience. No matter the budget, size, or location of the meeting, planners have more choices and concepts to draw upon than ever before.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7107853-marriott-meetingsimagined-com/
In his new book, award-winning author Donovan Webster embarks on an epic journey to meet his ancestral human family, following the path set by his DNA some 60,000 years ago. Meeting the Family is part genetic science, part travelogue, and totally fascinating. Learn more about this book here: http://tinyurl.com/35rfr3x Non-fiction
Video on us meeting thai women in phuket, thailand. We are out on the town and meeting several thai women in one night in Phuket Thailand. Come see more at: http://www.squidoo.com/meetthaiwomen
New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
Is there such a thing as a nonsurgical facelift? Aesthetic plastic surgeons are conducting a panel discussion at The Aesthetic Meeting 2015, the annual meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), to determine whether a nonsurgical facelift is a legitimate cosmetic procedure. Surgeons discussed what constitutes a nonsurgical facelift and how it impacts the longitudinal care aesthetic plastic surgeons can provide to address facial aging.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310754-asaps-nonsurgical-facelift/
The Advertising Council, in partnership with Autism Speaks, North America’s largest autism science and advocacy organization, announced today the launch of a new series of public service advertisements (PSAs) designed to raise awareness about autism and to empower parents to take action if their child is not meeting certain developmental milestones.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/45005/
Evidence from the Childhood Cancer Survivor Study suggests that changes in childhood cancer treatment have reduced deaths from the late effects of cancer treatment and extended the lives of childhood cancer survivors. St. Jude Children’s Research Hospital investigators led the research, which will be presented today at the plenary session of the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).
The study is one of four being featured at the plenary session press briefing, which highlights research that ASCO deems as having the highest scientific merit and greatest potential to affect patient care.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7532851-st-jude-cancer-research/
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
